Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines

Cancer Research

Volumn 59, Issue 9, 1999, Pages 2136-2141

  Spitzweg, Christine ^a   Zhang, Shaobo ^a   Bergert, Elizabeth R ^a   Castro, Maria R ^a   McIver, Bryan ^a   Heufelder, Armin E ^b   Tindall, Donald J ^a   Young, Charles Y F ^a   Morris, John C ^a  

^a MAYO CLINIC   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CARRIER PROTEIN; COMPLEMENTARY DNA; MIBOLERONE; PERCHLORATE; PROSTATE SPECIFIC ANTIGEN; SODIUM IODIDE;

ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE TARGETING; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER;

EID: 0033135063     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Steam, M. E., and McGarvey, T. Prostate cancer: therapeutics, diagnostic, and basic studies. Lab. Investig., 67: 540-552, 1992.
2. Carrasco, N. Iodide transport in the thyroid gland. Biochim. Biophys. Acta, 1154: 65-82, 1993.
3. Dai, G., Levy, O., and Carrasco, N. Cloning and characterization of the thyroid iodide transporter. Nature (Lond.), 379: 458-460, 1996.
4. Smanik, P. A., Liu, Q., Furminger, T. L., Ryu, K., Xing, S., Mazzaferri, E. L., and Jhiang, S. M. Cloning of the human sodium iodide symporter. Biochem. Biophys. Res. Commun., 226: 339-345, 1996.
5. - symporter gene. Mol. Endocrinol., 11: 1747-1755, 1997.
6. - symporter with an anti-COOH terminus antibody. Proc. Natl. Acad. Sci. USA, 94: 5568-5573, 1997.
7. Ohno, M., Zannini, M., Levy, O., Carrasco, N., and Di Lauro, R. Transcriptional regulation of the rat sodium/iodide symporter gene. Thyroid, 7 (Suppl. I): S-113, 1997.
8. Paire, A., Bernier-Valentin, F., Selmi-Ruby, S., and Rousset, B. Characterization of the rat thyroid iodide transporter using anti-peptide antibodies. J. Biol. Chem., 272: 18245-18249, 1997.
9. Smanik, P. A., Ryu, K-Y., Theil, K. S., Mazzaferri, E. L., and Jhiang, S. M. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology, 138: 3555-3558, 1997.
10. Spitzweg, C., Joba, W., Eisenmenger, W., and Heufelder, A. E. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J. Clin. Endocrinol. Metab., 83: 1746-1751, 1998.
11. Ajjan, R. A., Findlay, C., Metcalfe, R. A., Watson, P. F., Crisp, M., Ludgate, M., and Weetman, A. P. The modulation of the human sodium iodide symporter activity by Graves' disease sera. J. Clin. Endocrinol. Metab., 83: 1217-1221, 1998.
12. - symporter in human thyroid tissues and salivary gland tissues. Endocrinology, 139: 4416-4419, 1998.
13. - symporters. Biochem. Biophys. Res. Commun. 227: 94-101, 1996.
14. Young, C. Y. F., Andrews, P. E., and Tindall, D. J. Expression and androgenic regulation of human prostate-specific kallikreins. J. Androl., 16: 97-99, 1995.
15. Cleutjens, K. B. J. M., van der Korput, H. A. G. M., Ehren-van Eekelen, C. C., Sikes, R. A., Fasciana, C., Chung, L. W., and Trapman, J. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans. Mol. Endocrinol., 11: 1256-1265, 1997.
16. Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, E. A., and Murphy, G. P. LNCaP model of human prostatic carcinoma. Cancer Res., 43: 1809-1818, 1983.
17. Wu, H. C., Hsieh, J. T., Gleave, M. E., Brown, N. M., Pathak, S., and Chung, L. W. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int. J. Cancer, 57: 406-412, 1994.
18. Thalmann, G. N., Anezinis, P. E., Chang, S. M., Zhau, H. E., Kim, E. E., Hopwood, V. L., Pathak, S., von Eschenbach, A. C., and Chung, L. W. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res., 54: 2577-2581, 1994.
19. - transporting cultured thyroid cells. Proc. Natl. Acad. Sci., USA, 91: 3789-3793, 1994.
20. Weiss, S. J., Philip, N. J., and Grollmann, E. F. Iodine transport in a continuous line of cultured cells from rat thyroid. Endocrinology, 114: 1090-1098, 1984.
21. Saito, T., Endo, T., Kawaguchi, A., Ikeda, M., Katoh, R., Kawaoi, A., Muramatsu, A., and Onaya, T. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas. J. Clin. Investig., 101: 1296-1300, 1998.
22. Hart, I. R. Tissue specific promoters in targeting systemically delivered gene therapy. Semin. Oncol., 23: 154-158, 1996.
23. Vile, R. G., and Hart, I. R. In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res., 53: 962-967, 1993.
24. Riegman, P. H. J., Vlietstra, R. J., van der Korput, J. A. G. M., Brinkmann, A. O., and Trapman, J. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol. Endocrinol., 5: 1921-1930, 1991.
25. Zhang, J., Zhang, S., Murtha, P. E., Zhu, W., Hou, S. S-M., and Young, C. Y. F. Identification of two novel cis-elements in the promoter of the prostate-specific antigen gene that are required to enhance androgen receptor-mediated transactivation. Nucleic Acids Res., 25: 3143-3150, 1997.
26. Zhang, S., Murtha, P. E., and Young, C. Y. F. Defining a functional androgen responsive element in the 5′ far upstream flanking region of the prostate-specific antigen gene. Biochem. Biophys. Res. Commun., 231: 784-788, 1997.
27. Dannull, J., and Belldegrun, A. S. Development of gene therapy for prostate cancer using a novel promoter of prostate-specific antigen. Br. J. Urol., 79: 97-103, 1997.
28. Hrouda, D., and Dalgleish, A. G. Gene therapy for prostate cancer. Gene Ther., 3: 845-852, 1996.
29. Schuur, E. R., Henderson, G. A., Kmetec, L. A., Miller, J. D., Lamparski, H. G., and Henderson, D. R. Prostate-specific antigen expression is regulated by an upstream enhancer. J. Biol. Chem., 271: 7043-7051, 1996.
30. Wei, C., Willis, R. A., Tilton, B. R., Looney, R. J., Lord, E. M., Barth, R. K., and Frelinger, J. G. Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy. Proc. Natl. Acad. Sci. USA, 94: 6369-6374, 1997.
31. Lee, C-H., Liu, M., Sie, K-L., and Lee, M-S. Prostate-specific antigen promoter driven gene therapy targeting DNA polymerase-α and topoisomerase IIα in prostate cancer. Anticancer Res., 16: 1805-1812, 1996.
32. Cho, J. Y., Xing, S., Liu, X. L., Sferra, T., Chiu, I-M., and Jhiang, S. M. Expression and activity of human sodium iodide symporter in human glioma cells by adenovirus-mediated gene delivery. Proc. Am. Thyroid Assoc., P174, 1998.
33. - symporter gene. Endocrinology, 138: 4493-4496, 1997.
34. Montgomery, B. T., Young, C. Y. F., Bilhartz, D. L., Andrews, P. E., Prescott, J. L., Thompson, N. F., and Tindall, D. J. Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP. Prostate. 21: 63-73, 1992.
35. Young, C. Y. F., Andrews, P. E., Montgomery, B. T., and Tindall, D. J. Tissue-specific and hormonal regulation of humane prostate-specific glandular kallikrein. Biochemistry, 31: 818-824, 1992.
36. Murtha, P., Tindall, D. J., and Young, C. Y. F. Androgen induction of a human prostate-specific kallikrein. hKLK2: characterization of an androgen response element in the 5′ promoter region of the gene. Biochemistry, 32: 6459-6464, 1993.